default author photo

Catherine R. Marinac

Harvard University - Department of Medical Oncology

450 Brookline Avenue

Boston, MA 02115

United States

  • Harvard University - Department of Medical Oncology

SCHOLARLY PAPERS

5

DOWNLOADS

505

TOTAL CITATIONS

3

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study

Number of pages: 72 Posted: 03 Mar 2022
Habib El-Khoury, David J. Lee, Jean-Baptiste Alberge, Robert Redd, Christian J. Cea-Curry, Jacqueline Perry, Hadley Barr, Ciara Murphy, Dhananjay Sakrikar, David Barnidge, Mark Bustoros, Houry Leblebjian, Anna Cowan, Maya I. Davis, Julia Amstutz, Cody J. Boehner, Elizabeth D. Lightbody, Romanos Sklavenitis-Pistofidis, Mark C. Perkins, Stephen Harding, Clifton C. Mo, Prashant Kapoor, Joseph Mikhael, Ivan Borrello, Rafael Fonseca, Scott T. Weiss, Elizabeth W. Karlson, Lorenzo Trippa, Timothy Rebbeck, Gad Getz, Catherine R. Marinac and Irene Ghobrial
Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Inc., The Binding Site Inc., Cornell University - Weill Cornell Medicine, Harvard University - Department of Medical Oncology, Mayo Clinic - Alix School of Medicine, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Medical Oncology, Mayo Clinic, City of Hope - City of Hope Cancer Center, Johns Hopkins University - Johns Hopkins Hospital, Mayo Clinic, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 157 (474,889)
Citation 3

Abstract:

Loading...

Multiple myeloma, monoclonal gammopathy, cancer screening, mass spectrometry

2.

Mass Spectrometry-Detected Monoclonal Gammopathy of Undetermined Significance is Associated with Obesity and Other Novel Modifiable Risk Factors: Results of the Promise Study

Number of pages: 29 Posted: 04 Jan 2023
David J. Lee, Habib El-Khoury, Angela C. Tramontano, Jean-Baptiste Alberge, Jacqueline Perry, Maya I. Davis, Erica Horowitz, Robert Redd, Dhananjay Sakrikar, David Barnidge, Mark C. Perkins, Stephen Harding, Lorelei Mucci, Timothy Rebbeck, Irene Ghobrial and Catherine R. Marinac
Harvard University - Department of Medical Oncology, Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Division of Population Sciences, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, The Binding Site Inc., The Binding Site Inc., The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Epidemiology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 129 (561,789)

Abstract:

Loading...

MGUS, Multiple Myeloma, plasma cell dyscrasia, risk factors

3.

Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass Spectrometry

Number of pages: 28 Posted: 06 Dec 2021
Habib El-Khoury, David J. Lee, Jean-Baptiste Alberge, Robert Redd, Christian J. Cea-Curry, Jacqueline Perry, Hadley Barr, Ciara Murphy, Dhananjay Sakrikar, David Barnidge, Houry Leblebjian, Anna Cowan, Maya I. Davis, Julia Amstutz, Cody J. Boehner, Elizabeth D. Lightbody, Romanos Sklavenitis-Pistofidis, Mark C. Perkins, Stephen Harding, Clifton C. Mo, Scott T. Weiss, Elizabeth W. Karlson, Lorenzo Trippa, Gad Getz, Catherine R. Marinac and Irene Ghobrial
Harvard University - Center for Prevention of Progression of Blood Cancers, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Inc., The Binding Site Inc., Harvard University - Department of Medical Oncology, Mayo Clinic - Alix School of Medicine, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, Harvard University - Department of Medical Oncology, The Binding Site Group Ltd., The Binding Site Group Ltd., Harvard University - Department of Medical Oncology, Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Biostatistics and Computational Biology, Harvard University - Harvard Medical School, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 95 (720,278)

Abstract:

Loading...

Monoclonal gammopathy, Cancer screening, Early detection, Racial disparities, Mass spectrometry

4.

Patient Preferences for Intervention in the Setting of Precursor Multiple Myeloma

Number of pages: 15 Posted: 11 Jun 2024
Catherine R. Marinac, Katelyn Downey, Jacqueline Perry, Brittany Fisher-Longden, Timothy Rebbeck, Urvi Shah, Elizabeth O'Donnell, Irene Ghobrial, Omar Nadeem and Brian Egleston
Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute and Temple University - Fox Chase Cancer Center
Downloads 94 (720,278)

Abstract:

Loading...

prevention, interception, plasma cell disorder, precursor myeloma

5.

Regular Aspirin Use and Mortality in Multiple Myeloma Patients

Number of pages: 19 Posted: 21 Jul 2021
Catherine R. Marinac, Graham A. Colditz, Timothy Rebbeck, Bernard Rosner, Mark Bustoros, Irene Ghobrial and Brenda Birmann
Harvard University - Department of Medical Oncology, Washington University in St. Louis - Division of Public Health Sciences, Harvard University - Dana-Farber Cancer Institute, Harvard University - Channing Division of Network Medicine, Cornell University - Weill Cornell Medicine, Harvard University - Department of Medical Oncology and Harvard University - Channing Division of Network Medicine
Downloads 30 (1,318,317)

Abstract:

Loading...